XIAP deficiency syndrome in humans
- 1 March 2015
- journal article
- review article
- Published by Elsevier BV in Seminars in Cell & Developmental Biology
- Vol. 39, 115-123
- https://doi.org/10.1016/j.semcdb.2015.01.015
Abstract
No abstract availableKeywords
Funding Information
- Inserm
- ANR (ANR-14-CE14-0028-01, ANR-2010-MIDI-005-02, ANR-10-IAHU-01, ANR-08-MIEN-012-01)
- European Research Council (ERC-2009-AdG_20090506 n° FP7-249816)
This publication has 79 references indexed in Scilit:
- Host–microbe interactions have shaped the genetic architecture of inflammatory bowel diseaseNature, 2012
- IAPs limit activation of RIP kinases by TNF receptor 1 during developmentThe EMBO Journal, 2012
- Caspase-8 regulates TNF-α-induced epithelial necroptosis and terminal ileitisNature, 2011
- XIAP mediates NOD signaling via interaction with RIP2Proceedings of the National Academy of Sciences of the United States of America, 2009
- Activation of innate immune antiviral responses by Nod2Nature Immunology, 2009
- Patients with X-linked lymphoproliferative disease due to BIRC4 mutation have normal invariant natural killer T-cell populationsClinical Immunology, 2009
- XIAP as a ubiquitin ligase in cellular signalingCell Death & Differentiation, 2009
- IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-κB as well as cell survival and oncogenesisNature, 2008
- A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-κB activationThe EMBO Journal, 2007
- Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the familyEMBO Reports, 2006